Skip to main content

. 1987 Dec;50(12):1706–1707. doi: 10.1136/jnnp.50.12.1706

Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment.

C D Ward, J Thompson, M D Humby

PMCID: PMC1032625 PMID: 3437313

1706

Images in this article

Image
on p.1706

Image
on p.1706

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bowler J. V., Ormerod I. E., Legg N. J. Retroperitoneal fibrosis and bromocriptine. Lancet. 1986 Aug 23;2(8504):466–466. doi: 10.1016/s0140-6736(86)92178-1. [DOI] [PubMed] [Google Scholar]
Demonet J. F., Rostin M., Dueymes J. M., Ioualalen A., Montastruc J. L., Rascol A. Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine. Clin Neuropharmacol. 1986;9(2):200–201. doi: 10.1097/00002826-198604000-00012. [DOI] [PubMed] [Google Scholar]
Mitchinson M. J. Retroperitoneal fibrosis revisited. Arch Pathol Lab Med. 1986 Sep;110(9):784–786. [PubMed] [Google Scholar]
Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease. Lancet. 1981 Jan 3;1(8210):44–45. [PubMed] [Google Scholar]
Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease. Lancet. 1981 Jan 3;1(8210):44–45. [PubMed] [Google Scholar]

ACTIONS

RESOURCES